|
| 37963102 | Symptoms, Viral Loads, and Rebound Among COVID-19 Outpatients Treated With Nirmatrelvir/Ritonavir Compared With Propensity Score-Matched Untreated Individuals. | Clin Infect Dis | 2024 |
| 36193854 | Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. | Am J Epidemiol | 2023 |
| 37866991 | Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons. | Vaccine | 2023 |
| 38014151 | Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021-June 2022. | medRxiv | 2023 |
| 37590982 | Influenza Vaccination Among Pregnant People Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. | Obstet Gynecol | 2023 |
| 37610391 | COVID-19 Booster Dose Reminder/Recall for Adolescents: Findings From a Health-Care System in Wisconsin. | J Adolesc Health | 2023 |
| 37246146 | Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. | Influenza Other Respir Viruses | 2023 |
| 36960655 | Influenza Vaccine Effectiveness Among Children: 2011-2020. | Pediatrics | 2023 |
| 36814595 | Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink. | Vaccine X | 2023 |
| 36875208 | Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022. | Influenza Other Respir Viruses | 2023 |
| 36504336 | Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. | Clin Infect Dis | 2023 |
| 36701144 | Household Transmission of Influenza A Viruses in 2021-2022. | JAMA | 2023 |
| 36821715 | Interim Estimates of 2022-23 Seasonal Influenza Vaccine Effectiveness - Wisconsin, October 2022-February 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 35194642 | Household Transmission and Clinical Features of SARS-CoV-2 Infections. | Pediatrics | 2022 |
| 35710506 | Vaccine-associated attenuation of subjective severity among outpatients with influenza. | Vaccine | 2022 |
| 35755142 | Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas. | Vaccine X | 2022 |
| 35810274 | Human papillomavirus vaccine beliefs and practice characteristics in rural and urban adolescent care providers. | BMC Public Health | 2022 |
| 36577134 | Extended surveillance to assess safety of 9-valent human papillomavirus vaccine. | Hum Vaccin Immunother | 2022 |
| 36379754 | Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons. | Vaccine | 2022 |
| 34859584 | Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. | Influenza Other Respir Viruses | 2022 |
| 35178857 | mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021. | Influenza Other Respir Viruses | 2022 |
| 35271561 | Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35170231 | Vaccine effectiveness against COVID-19 among symptomatic persons aged â¿¥12 years with reported contact with COVID-19 cases, February-September 2021. | Influenza Other Respir Viruses | 2022 |
| 32505128 | Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018. | Clin Infect Dis | 2021 |
| 33597114 | Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019. | Vaccine | 2021 |
| 34498052 | Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged â¿¥16 Years in the United States, February-May 2021. | J Infect Dis | 2021 |
| 34426817 | Household Transmission and Clinical Features of SARS-CoV-2 Infections by Age in 2 US Communities. | medRxiv | 2021 |
| 34774360 | Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74Â years. | Vaccine | 2021 |
| 33994240 | Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States. | Vaccine | 2021 |
| 34245243 | Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial. | Clin Infect Dis | 2021 |
| 34169670 | Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019-2020 season. | Influenza Other Respir Viruses | 2021 |
| 34052066 | Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. | Vaccine | 2021 |
| 31988202 | Influenza Vaccine Effectiveness: New Insights and Challenges. | Cold Spring Harb Perspect Med | 2021 |
| 32006430 | Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017. | Clin Infect Dis | 2021 |
| 33090202 | Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children. | J Infect Dis | 2021 |
| 33367650 | Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020. | Clin Infect Dis | 2021 |
| 33382676 | Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020. | MMWR Morb Mortal Wkly Rep | 2021 |
| 30759228 | Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016. | J Pediatric Infect Dis Soc | 2020 |
| 33537361 | Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. | Open Forum Infect Dis | 2020 |
| 31753674 | Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15. | Vaccine | 2020 |
| 31992481 | Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016-17 season. | Vaccine | 2020 |
| 32078591 | Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020. | MMWR Morb Mortal Wkly Rep | 2020 |
| 31665373 | Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season. | J Infect Dis | 2020 |
| 31944583 | Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018. | Influenza Other Respir Viruses | 2020 |
| 33151916 | Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020. | MMWR Morb Mortal Wkly Rep | 2020 |
| 32633233 | Earliest infections predict the age distribution of seasonal influenza A cases. | Elife | 2020 |
| 32800465 | Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. | Vaccine | 2020 |
| 32390298 | Prediction of serious RSV-related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons. | Influenza Other Respir Viruses | 2020 |
| 32364599 | Patterns of Influenza Vaccination and Vaccine Effectiveness Among Young US Children Who Receive Outpatient Care for Acute Respiratory Tract Illness. | JAMA Pediatr | 2020 |
| 32527804 | COVID-19 and flu, a perfect storm. | Science | 2020 |